88038威尼斯(中国)有限公司
中文
英文
Home
About Us
Overview
Our People
Our Workplace
Products
Hypoglycemic drugs
Antineoplastic
Cardiovascular drugs
Others
Solutions
Chemistry
Custom Chemical Synthesis
FTE
Biology Services
In Vivo Efficacy Evaluation1
In Vitro Biological Screening
DMPK
In Vivo Pharmacokinetic Assays
In Vitro Pharmacokinetic Assays
Drug Safety Evaluation
Recruitment
Recruitment
Contact Us
中文版
Product center
Hypoglycemic drugs
Antineoplastic
Cardiovascular drugs
Others
Contact Us
Tel:
86-15000803246
Add:3rd Floor, Building 4, 3918 Daye Road, Fengxian District, Shanghai, China, 201401
Contact:Linna
Q Q:2300432737
E-mail:
sales-cpd@caerulumpharma.com
Web
:www.caerulumpharma.com
Products
No.
Product Name
CAS Number
Structure
CPDB1016
PF-06840003
198474-05-4
CPDB1021
GSK2256098; GTPL7939
1224887-10-8
CPDB1022
IPI-549
1693758-51-8
CPDB1062
AZD-3759
1626387-80-1
CPDB1064
EPZ-6438; Tazemetostat
1403254-99-8
CPDB1065
GSK-2816126
1346574-57-9
CPDB1093
ARQ-087
1234356-69-4
CPDB1110
CPI-444; V81444
1202402-40-1
CPDB1111
MAK683
1951408-58-4
CPDB1133
Vandetanib
443913-73-3
CPDB1134
Lapatinib Ditosylate Monohydrate
388082-78-8(Lapatinib Ditosylate Monohydrate), 231277-92-2(Lapatinib free base)
CPDB1135
Olmutinib; Olita®
1353550-13-6
CPDB1136
Erlotinib Hydrochloride; Tarceva®
183319-69-9 (HCl), 183321-74-6 (free)
CPDB1137
Neratinib; HKI-272; PB-272; PF-0528767; WAY-179272
698387-09-6 (free base);
915942-22-2 (Neratinib Maleate)
CPDB1138
Dacomitinib; PF-00299804; PF-299; PF-299804; PF-804; PF-00299804-03; PF-00299804-3
1042385-75-0 (Dacomitinib Monohydrate), 1110813-31-4 (Dacomitinib free base)
61
62
63
64
65
66
67
68
69
70
Copyright 2014 Shanghai Caerulum Pharma Discovery Co.,Ltd. All rights reserved. Supported by
www.hxchem.net